Regulus Therapeutics Inc. (Nasdaq: RGLS) president and chief executive
Kleanthis G. Xanthopoulos has resigned sending the stock price
plummeting $2.25 to close at $11.53.
Regulus Therapeutics CEO resigns
June 02, 2015 at 19:13 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.